Literature DB >> 33679756

Serological Levels of Anti-clathrin Antibodies Are Decreased in Patients With Pseudoexfoliation Glaucoma.

Vanessa M Beutgen1, Norbert Pfeiffer1, Franz H Grus1.   

Abstract

Evidence for immunologic contribution to glaucoma pathophysiology is steadily increasing in ophthalmic research. Particularly, an altered abundance of circulating autoantibodies to ocular antigens is frequently observed. Here, we report an analysis of autoantibody abundancies to selected antigens in sera of open-angle glaucoma patients, subdivided into normal-tension glaucoma (N = 31), primary open-angle glaucoma (N = 43) and pseudoexfoliation glaucoma (N = 45), vs. a non-glaucomatous control group (N = 46). Serum samples were analyzed by protein microarray, including 38 antigens. Differences in antibody levels were assessed by ANOVA. Five serological antibodies showed significantly altered levels among the four groups (P < 0.05), which can be used to cluster the subjects in groups consisting mainly of PEXG or POAG/NTG samples. Among the altered autoantibodies, anti-Clathrin antibodies were identified as most important subgroup predictors, enhancing prospective glaucoma subtype prediction. As a second aim, we wanted to gain further insights into the characteristics of previously identified glaucoma-related antigens and their role in glaucoma pathogenesis. To this end, we used the bioinformatics toolset of Metascape to construct protein-protein interaction networks and GO enrichment analysis. Glaucoma-related antigens were significantly enriched in 13 biological processes, including mRNA metabolism, protein folding, blood coagulation and apoptosis, proposing a link of glaucoma-associated pathways to changes in the autoantibody repertoire. In conclusion, our study provides new aspects of the involvement of natural autoimmunity in glaucoma pathomechanisms and promotes advanced opportunities toward new diagnostic approaches.
Copyright © 2021 Beutgen, Pfeiffer and Grus.

Entities:  

Keywords:  autoantibodies; autoimmunity; bioinformatics; glaucoma; immunoproteomics; microarray

Mesh:

Substances:

Year:  2021        PMID: 33679756      PMCID: PMC7933590          DOI: 10.3389/fimmu.2021.616421

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  53 in total

Review 1.  A molecular mechanism for glaucoma: endoplasmic reticulum stress and the unfolded protein response.

Authors:  Robert R H Anholt; Mary Anna Carbone
Journal:  Trends Mol Med       Date:  2013-07-19       Impact factor: 11.951

Review 2.  Pseudoexfoliation syndrome for the comprehensive ophthalmologist. Intraocular and systemic manifestations.

Authors:  G O Naumann; U Schlötzer-Schrehardt; M Küchle
Journal:  Ophthalmology       Date:  1998-06       Impact factor: 12.079

3.  Increased Endoplasmic Reticulum Stress in Human Glaucomatous Trabecular Meshwork Cells and Tissues.

Authors:  Joseph C Peters; Sanjoy Bhattacharya; Abbot F Clark; Gulab S Zode
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-06       Impact factor: 4.799

4.  Anti-Ro/SS-A positivity and heat shock protein antibodies in patients with normal-pressure glaucoma.

Authors:  M B Wax; G Tezel; I Saito; R S Gupta; J B Harley; Z Li; C Romano
Journal:  Am J Ophthalmol       Date:  1998-02       Impact factor: 5.258

5.  Oxidative stress and the regulation of complement activation in human glaucoma.

Authors:  Gülgün Tezel; Xiangjun Yang; Cheng Luo; Angela D Kain; David W Powell; Markus H Kuehn; Henry J Kaplan
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-05-19       Impact factor: 4.799

6.  Differential gene expression in pseudoexfoliation syndrome.

Authors:  Matthias Zenkel; Ernst Pöschl; Klaus von der Mark; Carmen Hofmann-Rummelt; Gottfried O H Naumann; Friedrich E Kruse; Ursula Schlötzer-Schrehardt
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-10       Impact factor: 4.799

Review 7.  Normal-tension glaucoma: an update.

Authors:  Bruno Leonardo Barranco Esporcatte; Ivan Maynart Tavares
Journal:  Arq Bras Oftalmol       Date:  2016 Jul-Aug       Impact factor: 0.872

8.  Altered stability of mRNAs associated with glaucoma progression in human trabecular meshwork cells following oxidative stress.

Authors:  Hideki Mochizuki; Christopher J Murphy; James D Brandt; Yoshiaki Kiuchi; Paul Russell
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-04-02       Impact factor: 4.799

9.  Autoantibodies to small heat shock proteins in glaucoma.

Authors:  G Tezel; G M Seigel; M B Wax
Journal:  Invest Ophthalmol Vis Sci       Date:  1998-11       Impact factor: 4.799

10.  European Glaucoma Society Terminology and Guidelines for Glaucoma, 4th Edition - Chapter 2: Classification and terminologySupported by the EGS Foundation: Part 1: Foreword; Introduction; Glossary; Chapter 2 Classification and Terminology.

Authors: 
Journal:  Br J Ophthalmol       Date:  2017-04-18       Impact factor: 4.638

View more
  2 in total

1.  A Monoclonal Anti-HMGB1 Antibody Attenuates Neurodegeneration in an Experimental Animal Model of Glaucoma.

Authors:  Henrik Tonner; Selina Hunn; Nadine Auler; Carsten Schmelter; Vanessa M Beutgen; Harald D von Pein; Norbert Pfeiffer; Franz H Grus
Journal:  Int J Mol Sci       Date:  2022-04-07       Impact factor: 6.208

Review 2.  Antibody and Protein Profiles in Glaucoma: Screening of Biomarkers and Identification of Signaling Pathways.

Authors:  Nadine Auler; Henrik Tonner; Norbert Pfeiffer; Franz H Grus
Journal:  Biology (Basel)       Date:  2021-12-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.